Literature DB >> 33443701

Primary Care and Pre-exposure Prophylaxis Services in Publicly Funded Family Planning Clinics in the Southern United States.

Caroline G Coleman1, Jessica M Sales2, Cam Escoffery2, Kaitlin N Piper2, Leah Powell2, Anandi N Sheth3,4,5.   

Abstract

BACKGROUND: HIV pre-exposure prophylaxis (PrEP) is underutilized by US women. Cost and resource concerns are barriers to PrEP delivery in settings that see men. Family planning clinics may be ideal PrEP delivery settings for women, but as they are not uniform in their clinical services, cost and resource concerns may vary.
OBJECTIVE: We examined factors that influence perceptions of costs and resources related to PrEP delivery in Title X-funded family planning clinics in Southern states, which overlaps with high HIV-burden areas.
DESIGN: We conducted a web-based survey among a convenience sample of clinicians and administrators of Title X clinics across 18 Southern states (DHHS regions III, IV, VI). We compared cost- and resource-related survey items and other clinic- and county-level variables between clinics by whether their clinics also provided other primary care services. We analyzed interviews for cost and resource themes. PARTICIPANTS: Title X clinic staff in the South. KEY
RESULTS: Among 283 unique clinics, a greater proportion of clinics that also provided primary care currently provided PrEP compared with those that did not provide primary care (27.8% vs. 18.3%, p = 0.06), but this difference was not statistically significant. Among 414 respondents in clinics that were not providing PrEP, those in clinics with primary care services were more likely to respond that they had the necessary financial resources (p < 0.01) and staffing (p < 0.01) for PrEP implementation compared to those without primary care services. In interviews, respondents differed on concerns about costs of labs and staffing based on whether their clinic had concomitant primary care services or not.
CONCLUSIONS: Among publicly funded Southern family planning clinics, current PrEP provision was higher among clinics with concomitant primary care. Among clinics not providing PrEP, those with concomitant primary care services have lower perceived cost and resource barriers and therefore may be optimal for expanding PrEP among women.
© 2021. Society of General Internal Medicine.

Entities:  

Keywords:  HIV; PrEP; Title X; family planning; women’s health

Mesh:

Substances:

Year:  2021        PMID: 33443701      PMCID: PMC8481449          DOI: 10.1007/s11606-020-06509-3

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   6.473


  16 in total

1.  Family planning clinic patients: their usual health care providers, insurance status, and implications for managed care.

Authors:  S Sugerman; N Halfon; A Fink; M Anderson; L Valle; R H Brook
Journal:  J Adolesc Health       Date:  2000-07       Impact factor: 5.012

2.  United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.

Authors:  Dominika Seidman; Kimberly Carlson; Shannon Weber; Jacki Witt; Patricia J Kelly
Journal:  Contraception       Date:  2016-01-06       Impact factor: 3.375

Review 3.  Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.

Authors:  Julia L Marcus; Jonathan E Volk; Jess Pinder; Albert Y Liu; Oliver Bacon; C Bradley Hare; Stephanie E Cohen
Journal:  Curr HIV/AIDS Rep       Date:  2016-04       Impact factor: 5.071

4.  The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.

Authors:  Aaron J Siegler; Farah Mouhanna; Robertino Mera Giler; Kevin Weiss; Elizabeth Pembleton; Jodie Guest; Jeb Jones; Amanda Castel; Howa Yeung; Michael Kramer; Scott McCallister; Patrick S Sullivan
Journal:  Ann Epidemiol       Date:  2018-06-15       Impact factor: 3.797

5.  Brief Report: PrEP Eligibility Among At-Risk Women in the Southern United States: Associated Factors, Awareness, and Acceptability.

Authors:  Anar S Patel; Lakshmi Goparaju; Jessica M Sales; Cyra Christina Mehta; Oni J Blackstock; Dominika Seidman; Igho Ofotokun; Mirjam-Colette Kempf; Margaret A Fischl; Elizabeth T Golub; Adaora A Adimora; Audrey L French; Jack DeHovitz; Gina Wingood; Seble Kassaye; Anandi N Sheth
Journal:  J Acquir Immune Defic Syndr       Date:  2019-04-15       Impact factor: 3.731

Review 6.  Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women.

Authors:  Kerry A Thomson; Jared M Baeten; Nelly R Mugo; Linda-Gail Bekker; Connie L Celum; Renee Heffron
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

7.  Models of HIV Pre-Exposure Prophylaxis Care Used in Title X Family Planning Clinics in the Southern U.S.

Authors:  Kaitlin N Piper; Cam Escoffery; Jessica M Sales; Anandi N Sheth
Journal:  J Adolesc Health       Date:  2020-11-05       Impact factor: 5.012

8.  Pre-exposure Prophylaxis Implementation in Family Planning Services Across the Southern United States: Findings from a Survey Among Staff, Providers and Administrators Working in Title X-Funded Clinics.

Authors:  Jessica M Sales; Cam Escoffery; Sophia A Hussen; Lisa B Haddad; Micah McCumber; Evan Kwiatkowski; Teresa Filipowicz; Maria Sanchez; Matthew A Psioda; Anandi N Sheth
Journal:  AIDS Behav       Date:  2021-01-23

9.  Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention.

Authors:  Rupa R Patel; Leandro Mena; Amy Nunn; Timothy McBride; Laura C Harrison; Catherine E Oldenburg; Jingxia Liu; Kenneth H Mayer; Philip A Chan
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

10.  Pre-Exposure Prophylaxis Integration into Family Planning Services at Title X Clinics in the Southeastern United States: A Geographically-Targeted Mixed Methods Study (Phase 1 ATN 155).

Authors:  Jessica M Sales; Cam Escoffery; Sophia A Hussen; Lisa B Haddad; Ashley Phillips; Teresa Filipowicz; Maria Sanchez; Micah McCumber; Betty Rupp; Evan Kwiatkowski; Matthew A Psioda; Anandi N Sheth
Journal:  JMIR Res Protoc       Date:  2019-05-06
View more
  2 in total

1.  Provider Perspectives on Factors Affecting the PrEP Care Continuum Among Black Cisgender Women in the Midwest United States: Applying the Consolidated Framework for Implementation Research.

Authors:  Amy K Johnson; Maria Pyra; Samantha Devlin; A Ziggy Uvin; Shemeka Irby; Cori Blum; Eric Stewart; Lisa Masinter; Sadia Haider; Lisa R Hirschhorn; Jessica P Ridgway
Journal:  J Acquir Immune Defic Syndr       Date:  2022-07-01       Impact factor: 3.771

2.  Tennessee Pharmacists' Opinions on Barriers and Facilitators to Initiate PrEP: A Qualitative Study.

Authors:  Alina Cernasev; Crystal Walker; Caylin Kerr; Rachel E Barenie; Drew Armstrong; Jay Golden
Journal:  Int J Environ Res Public Health       Date:  2022-07-10       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.